
Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges
2026-04-15 08:02:37Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from an expensive to a very expensive rating. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios reveal a complex picture of price attractiveness relative to peers and historical benchmarks.
Read full news article
Tyche Industries Ltd Valuation Shift Signals Price Attractiveness Change
2026-04-09 08:01:37Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions and impacts the stock's price attractiveness relative to its historical averages and peer group, amid a challenging industry backdrop and mixed financial performance.
Read full news article
Tyche Industries Ltd is Rated Strong Sell
2026-04-06 10:10:39Tyche Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 06 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Tyche Industries Ltd is Rated Strong Sell
2026-03-26 10:10:36Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Tyche Industries Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges
2026-03-24 08:01:47Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate sharply, with its price-to-earnings (P/E) ratio and price-to-book value (P/BV) signalling a shift from expensive to very expensive territory. This re-rating comes amid subdued financial performance and a challenging sector backdrop, raising concerns about the stock’s price attractiveness relative to peers and historical benchmarks.
Read full news article
Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Challenges
2026-03-18 08:00:59Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change accompanies a downgrade in its Mojo Grade to Strong Sell, reflecting growing concerns over its price attractiveness relative to historical and peer benchmarks.
Read full news article
Tyche Industries Ltd is Rated Strong Sell
2026-03-15 10:10:23Tyche Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Tyche Industries Ltd Valuation Shifts Signal Price Attractiveness Decline
2026-03-11 08:01:06Tyche Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions and impacts the stock's price attractiveness amid a challenging industry backdrop and mixed financial metrics.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI(D&P)Regulations2018 for the Quarter ended March 31 2026
Closure of Trading Window
25-Mar-2026 | Source : BSEThe Trading window of the Company shall remain closed w.e.f April 1 2026 till the expiry of 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and Year ended March 31 2026.
Intimation Regarding Receipt Of ANVISA Brazil GMP Certificate For The Companys Manufacturing Facility Located At Kakinada Andhra Pradesh.
24-Mar-2026 | Source : BSEPlease find attached the intimation regarding receipt of ANVISA Brazil GMP certificate for the Companys Manufacturing facility located at Kakinada Andhra Pradesh.
Corporate Actions
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available







